Back to Search
Start Over
Eirion Therapeutics Announces Initiation of First-in-Human Clinical Trial Evaluating Next Generation, Ready-to-Use Liquid Injectable Neuromodulator AI-09 for the Treatment of Wrinkles
- Source :
- PR Newswire. October 17, 2022
- Publication Year :
- 2022
-
Abstract
- Company Also Announces Update for Its Lead, Phase 2b Product CandidateTopical Neuromodulator ET-01 WOBURN, Mass., Oct. 17, 2022 /PRNewswire/ -- Eirion Therapeutics Inc. announced today that the first participants have [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- PR Newswire
- Publication Type :
- News
- Accession number :
- edsgcl.722755567